Journal IJCRT UGC-CARE, UGCCARE( ISSN: 2320-2882 ) | UGC Approved Journal | UGC Journal | UGC CARE Journal | UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, International Peer Reviewed Journal and Refereed Journal, ugc approved journal, UGC CARE, UGC CARE list, UGC CARE list of Journal, UGCCARE, care journal list, UGC-CARE list, New UGC-CARE Reference List, New ugc care journal list, Research Journal, Research Journal Publication, Research Paper, Low cost research journal, Free of cost paper publication in Research Journal, High impact factor journal, Journal, Research paper journal, UGC CARE journal, UGC CARE Journals, ugc care list of journal, ugc approved list, ugc approved list of journal, Follow ugc approved journal, UGC CARE Journal, ugc approved list of journal, ugc care journal, UGC CARE list, UGC-CARE, care journal, UGC-CARE list, Journal publication, ISSN approved, Research journal, research paper, research paper publication, research journal publication, high impact factor, free publication, index journal, publish paper, publish Research paper, low cost publication, ugc approved journal, UGC CARE, ugc approved list of journal, ugc care journal, UGC CARE list, UGCCARE, care journal, UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, ugc care list of journal, ugc care list 2020, ugc care approved journal, ugc care list 2020, new ugc approved journal in 2020, ugc care list 2021, ugc approved journal in 2021, Scopus, web of Science.
How start New Journal & software Book & Thesis Publications
Submit Your Paper
Login to Author Home
Communication Guidelines

WhatsApp Contact
Click Here

  Published Paper Details:

ugc approved journal, UGC CARE Journal, ugc approved list of journal, ugc care journal, UGC CARE list, UGC-CARE, care journal, UGC-CARE list, Journal publication, ISSN approved, Research journal, research paper, research paper publication

  Authors

SHUBHAM DATTATRAY DESHMUKH,SMITA S AHER

  Keywords

HIV, Antiretroviral therapy, Pre-exposure prophylaxis ,CD4

  Abstract


HIV (Human Immunodeficiency Virus) is a global health concern that affects millions of people worldwide. This abstract provides an overview of HIV and its available treatments. HIV is a retrovirus that primarily targets the immune system, specifically CD4+ T cells, leading to a progressive decline in the body's ability to fight off infections and diseases. It is transmitted through certain body fluids, such as blood, semen, vaginal fluids, and breast milk, commonly through sexual intercourse, sharing needles, or from mother to child during childbirth or breastfeeding. Antiretroviral therapy (ART) is the cornerstone of HIV treatment. ART consists of a combination of different antiretroviral drugs that inhibit various stages of the viral life cycle. These medications work by suppressing viral replication, reducing viral load, preserving immune function, and slowing down disease progression. There are several classes of antiretroviral drugs, including nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), integrase strand transfer inhibitors (INSTIs), and entry inhibitors. Treatment regimens typically involve a combination of drugs from different classes to maximize effectiveness and minimize the risk of drug resistance. Early initiation of ART after HIV diagnosis is crucial for optimal outcomes. Treatment aims to achieve and maintain an undetectable viral load, which reduces the risk of HIV transmission and helps preserve the immune system. Regular monitoring of viral load and CD4+ cell count is essential to assess treatment response and make necessary adjustments. In addition to ART, other strategies such as pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) are available for HIV prevention. PrEP involves taking antiretroviral medications before potential exposure to HIV to reduce the risk of infection. PEP, on the other hand, involves taking a short course of antiretroviral drugs after a potential exposure to prevent HIV transmission. While significant progress has been made in HIV treatment, challenges remain. Adherence to lifelong treatment, potential side effects of medications, the emergence of drug resistance, and access to healthcare and medications are among the ongoing concerns. In conclusion, HIV remains a significant global health challenge, but with the availability of antiretroviral therapy, it is now a manageable chronic condition. Timely diagnosis, early initiation of ART, and consistent adherence to treatment are crucial for improving outcomes and reducing the impact of HIV on individuals and communities. Continued research, education, and access to affordable medications are essential for achieving the goal of ending the HIV epidemic.

  IJCRT's Publication Details

  Unique Identification Number - IJCRT23A5079

  Paper ID - 237577

  Author type - Indian Author

  Page Number(s) - i853-i860

  Pubished in - Volume 11 | Issue 5 | May 2023

  DOI (Digital Object Identifier) -   

  No Of Downloads - 60

  Author Country - India, 422611, Sangamner, Sangamner, 422611, Pharmacy All

  Publisher Name - IJPUBLICATION | www.ijcrt.org | ISSN : 2320-2882

  E-ISSN Number - 2320-2882

  Published Paper PDF : - http://www.ijcrt.org/papers/IJCRT23A5079

  Published Paper URL: : - http://ijcrt.org/viewfull.php?&p_id=IJCRT23A5079

  Published Paper PDF Downlaod: - download.php?file=IJCRT23A5079

  Cite this article

SHUBHAM DATTATRAY DESHMUKH,SMITA S AHER,   "New developments in treatment of HIV", International Journal of Creative Research Thoughts (IJCRT), ISSN:2320-2882, Volume.11, Issue 5, pp.i853-i860, May 2023, Available at :http://www.ijcrt.org/papers/IJCRT23A5079.pdf

  Share this article

  Article Preview

  Types of Articles invited

Research Papers, Survey Papers, Study Papers, Subjective Papers, Experimental Result Papers, Analysis Study Research Papers, Informative Article, Comparison Papers, Case Studies Papers, Review Papers, Comparative Studies, Dissertation Chapters, Research Proposals or Synopsis, Working Projects, New Innovation & Idea, Prototypes and Models and many More

  Call For Paper

  About IJCRT (Refereed Journal, Peer Journal and Indexed Journal )

About IJCRT

The International Journal of Creative Research Thoughts (IJCRT) aims to explore advances in research pertaining to applied, theoretical and experimental Technological studies. The goal is to promote scientific information interchange between researchers, developers, engineers, students, and practitioners working in and around the world.

IJCRT is Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 7.97 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool), Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

The open access supports the rights of users to read, download, copy, distribute, print, search, or link to the full texts of these articles provided they are properly acknowledged and cited.


Indexing In Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar | AI-Powered Research Tool, Microsoft Academic, Academia.edu, arXiv.org, Research Gate, CiteSeerX, ResearcherID Thomson Reuters, Mendeley : reference manager, DocStoc, ISSUU, Scribd, and many more

International Journal of Creative Research Thoughts (IJCRT)
ISSN: 2320-2882 | Impact Factor: 7.97 | Impact Factor: 7.97 and Monthly-Peer-reviewed, and Refereed Journals.
Open Access Processing Charges or Publication fees with free DOI : ₹1500 INR for Indian author & 55$ for foreign International author.

Refereed Journal, Peer Journal and Indexed Journal
Publication Issue Frequency : Monthly (12 issue Per Year Annually)
Journal Discipline and Subject : Multidisciplinary,Monthly,Multilanguage (Regional language supported) .
Publisher and Managed By : IJPUBLICATION (ijpublication.org).
Publication Supported Languages: Allow All Multiple Languages (Regional language supported).


Provide DOI and Hard copy of Certificate.
High impact factor and 50+ index database and Fast paper publication.
Nominal Fee for Professional Research Services, Low cost research journal.
Publication Guidelines : COPE Guidelines
Quick, Fast, automatic Speedy Review and publication Process
Notification of Review Result and publication - Within 02-03 Days.
Provide Free e-certificate to all author and DOI (Digital Object Identifiers) to All Paper.
Download all digital data from website anytime lifetime available.
Indexing of paper in all major online journal databases.

Low Publication Charge 1500 INR per single paper Publication with Maximum 5 Author for indian author & 55$ for foreign International author.

Paper Submission Till : 29 May 2024
Review Results (Acceptance/Rejection) Notification : Within 02-03 Days
Paper Publication Time : Paper Publish: Within 02-03 Days after submitting all the required documents.

Submit your Paper Submit your paper


Call For Paper (Volume 12 | Issue 5 | Month- May 2024)

Licence and Indexing

Indexing In Google Scholar, ResearcherID Thomson Reuters, Mendeley : reference manager, Academia.edu, arXiv.org, Research Gate, CiteSeerX, DocStoc, ISSUU, Scribd, and many more | High Impact Factor: 7.97 | Digital object identifier (DOI) and Hard Copy of certificate Provided.







Licence

DOIIJCRT Research Journal
ISSN Approved
Impact Factor: 7.97 IJCRT Research Journal
Creative Common IJCRT Research Journal
Valid as per new UGC Gazette regulations IJCRT Research Journal

Features

Impact Factor: 7.97 and ISSN approved.
Impact Factor: 7.97 Calculated by google scholar
Call For Paper (Volume 12 | Issue 5 | Month- May 2024)
Quick, Fast, automatic Speedy Review Process
Notification of Review Result - Within 02-03 Days.
Publication of Paper - Within 02-03 Days.

Provide Free DOI(Digital Object Identifiers) to All Paper.
Provide Hard copy of certificate based on request.
Indexing of paper in all major online journal databases.
SEO effective and Automated Metadata Citation Generator.

Open-Access peer reviewed International Journal
Fully Automated and Secure https Website
Author can Check Publication Process status online.
EMail and SMS notification to the author for each Process stage.
Paper and Soft Copy of "Certificate" Available life time on website.

Qualifed & Experience Reviewers from Well-known Institutes/Universities among the world.
Social Media, Email and Call Support 24*7.
Google Scholar, ResearcherID Thomson Reuters Indexing.
Author Research Guidelines & Support.

  Indexing Partners

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
Call For Paper May 2024
Indexing Partner
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
DOI Details

Providing A Free digital object identifier by DOI.one How to get DOI?
For Reviewer /Referral (RMS) Earn 500 per paper
Our Social Link
Open Access
This material is Open Knowledge
This material is Open Data
This material is Open Content
Indexing Partner

Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 7.97 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer